Online first
Case report
Published online: 2024-04-24

open access

Page views 78
Article views/downloads 56
Get Citation

Connect on Social Media

Connect on Social Media

An early diagnosed medulloblastoma of the vermis

Mansour Parvaresh1, Hesam Ghadirian2, Arash Fattahi1, Alireza Sadeghipour3

Abstract

Introduction: Medulloblastoma is categorized into different histological and molecular subtypes with unique characteristics that make diagnosis challenging. We present a case of a 30-year-old male with continuous nausea and vomiting for 3 months ago. Imaging revealed a brief signal change in the vermis. He had normal results of neurologic examinations. The lesion was completely removed surgically. The histopathology exam revealed classic medulloblastoma, non-SHH, and non-WNT, and the patient was referred for adjuvant therapy. In this case, the low intensity of changes confined to the vermis, without edema and gadolinium enhancement ruled out medulloblastoma. The WNT was a more probable subtype, but histopathology ruled that out. It seems that the decision to operate on this patient was the best approach because this surgery sped up the diagnosis and his chemoradiotherapy started sooner. In conclusion, in the case of lesions in the posterior fossa, medulloblastoma should always be kept in mind because an early diagnosis can improve the prognosis. 

Article available in PDF format

View PDF Download PDF file

References

  1. Qin Q, Huang D, Jiang Y. Survival difference between brainstem and cerebellum medulloblastoma: the surveillance, epidemiology, and end results-based study. Medicine (Baltimore). 2020; 99(41): e22366.
  2. Juraschka K, Taylor MD. Medulloblastoma in the age of molecular subgroups: a review. J Neurosurg Pediatr. 2019; 24(4): 353–363.
  3. Louis DN, Perry A, Wesseling P, et al. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol. 2016; 131(6): 803–820.
  4. Mrinal B, Hriday H, Basanta K, et al. A Clinical Study of medulloblastoma in Correlation with Molecular Biology and Histological Variations in Childhood medulloblastoma in Northeast India. Indian Journal of Neurosurgery. 2019; 8: 155–160.
  5. Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007; 114(2): 97–109.
  6. Kool M, Korshunov A, Remke M, et al. Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas. Acta Neuropathol. 2012; 123(4): 473–484.
  7. Waite KA, Cioffi G, Kruchko C, et al. Aligning the Central Brain Tumor Registry of the United States (CBTRUS) histology groupings with current definitions. Neurooncol Pract. 2022; 9(4): 317–327.
  8. Fellay CN, Frappaz D, Sunyach MP, et al. Medulloblastomas in adults: prognostic factors and lessons from paediatrics. Curr Opin Neurol. 2011; 24(6): 626–632.
  9. Gajjar AJ, Robinson GW. Medulloblastoma-translating discoveries from the bench to the bedside. Nat Rev Clin Oncol. 2014; 11(12): 714–722.
  10. Dangouloff-Ros V, Varlet P, Levy R, et al. Imaging features of medulloblastoma: Conventional imaging, diffusion-weighted imaging, perfusion-weighted imaging, and spectroscopy: From general features to subtypes and characteristics. Neurochirurgie. 2021; 67(1): 6–13.
  11. Zhang Na, Ouyang T, Kang H, et al. Adult medulloblastoma: clinical characters, prognostic factors, outcomes and patterns of relapse. J Neurooncol. 2015; 124(2): 255–264.
  12. Zhao Fu, Ohgaki H, Xu L, et al. Molecular subgroups of adult medulloblastoma: a long-term single-institution study. Neuro Oncol. 2016; 18(7): 982–990.
  13. Shonka N, Brandes A, De Gr. Adult medulloblastoma, from spongioblastoma cerebelli to the present day: a review of treatment and the integration of molecular markers. Oncology. 2012; 26: 1083–1091.